Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

The integrin alpha(v)beta3 has been shown to act as the receptor for internalization of foot-and-mouth disease virus (FMDV) (A12), with attachment being through a highly conserved RGD motif located on the G-H loop of viral capsid protein VP1. In addition, however, we have recently shown that efficie...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Jackson, T, Sharma, A, Ghazaleh, R, Blakemore, W, Ellard, F, Simmons, D, Newman, J, Stuart, D, King, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	1997

Documenti analoghi

The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.
di: Fry, E, et al.
Pubblicazione: (1999)

Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.
di: Jackson, T, et al.
Pubblicazione: (1996)

Utility of recombinant integrin alpha v beta6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease.
di: Ferris, N, et al.
Pubblicazione: (2005)

Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine–Glycine–Aspartate) Strategies
di: Bojana Bogdanović, et al.
Pubblicazione: (2024-11-01)

Crystallization and preliminary X-ray analysis of three serotypes of foot-and-mouth disease virus.
di: Curry, S, et al.
Pubblicazione: (1992)

Structure of a major immunogenic site on foot-and-mouth disease virus.
di: Logan, D, et al.
Pubblicazione: (1993)

Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids.
di: Ellard, F, et al.
Pubblicazione: (1999)

Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.
di: Curry, S, et al.
Pubblicazione: (1997)

Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
di: Lea, S, et al.
Pubblicazione: (1995)

Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity.
di: Curry, S, et al.
Pubblicazione: (1996)

Enhanced attachment and growth of periodontal cells on glycine-arginine-glycine-aspartic modified chitosan membranes
di: Hsiao-Pei Tu, et al.
Pubblicazione: (2016-01-01)

Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins.
di: Burman, A, et al.
Pubblicazione: (2006)

The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions.
di: Rowlands, D, et al.
Pubblicazione: (1994)

The structure and antigenicity of a type C foot-and-mouth disease virus.
di: Lea, S, et al.
Pubblicazione: (1994)

Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus.
di: Sharma, A, et al.
Pubblicazione: (1997)

Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation.
di: Fry, E, et al.
Pubblicazione: (2005)

Examination of soluble integrin resistant mutants of foot-and-mouth disease virus
di: Lawrence Paul, et al.
Pubblicazione: (2013-01-01)

Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus.
di: Kotecha, A, et al.
Pubblicazione: (2017)

Indocyanine Green and Arginine-Glycine-Aspartic Acid Complex Used in Intraoperative Visualization during Resection of Bladder Tumour
di: Li Peng, et al.
Pubblicazione: (2019-01-01)

Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation
di: Chen Wang, et al.
Pubblicazione: (2022-04-01)

Cyclic Arginine–Glycine–Aspartate‐Decorated Lipid Nanoparticle Targeting toward Inflammatory Lesions Involves Hitchhiking with Phagocytes
di: Alexandros Marios Sofias, et al.
Pubblicazione: (2021-07-01)

Characterization of a Functionally Unknown Arginine–Aspartate–Aspartate Family Protein From Halobacillus andaensis and Functional Analysis of Its Conserved Arginine/Aspartate Residues
di: Li Shao, et al.
Pubblicazione: (2018-04-01)

Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus
di: Abhay Kotecha, et al.
Pubblicazione: (2017-05-01)

Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
di: Hewat, E, et al.
Pubblicazione: (1997)

The structure of foot-and-mouth disease virus.
di: Fry, E, et al.
Pubblicazione: (2005)

Effects of arginine–glycine–aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo
di: Li MM, et al.
Pubblicazione: (2017-04-01)

Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
di: Jiang K, et al.
Pubblicazione: (2018-04-01)

Arginine Methylation of Integrin Alpha-4 Prevents Fibrosis Development in Alcohol-Associated Liver DiseaseSummary
di: Michael Schonfeld, et al.
Pubblicazione: (2023-01-01)

STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS
di: Acharya, R, et al.
Pubblicazione: (1990)

Toxicity assessment of repeated intravenous injections of arginine–glycine–aspartic acid peptide conjugated CdSeTe/ZnS quantum dots in mice
di: Wang YW, et al.
Pubblicazione: (2014-10-01)

Characterization of epitope-tagged foot-and-mouth disease virus.
di: Seago, J, et al.
Pubblicazione: (2012)

Arginine depletion-induced autophagy and metabolic dysregulation are involved in the disease severity of hand, foot, and mouth disease
di: Yuefei Jin, et al.
Pubblicazione: (2025-12-01)

Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen
di: P Hosseini, et al.
Pubblicazione: (2016-11-01)

Xylazine regulates the release of glycine and aspartic acid in rat brain
di: Zhang Yi-Ming, et al.
Pubblicazione: (2018-03-01)

Homoarginine, the methylene homologue of arginine, as a substrate of human arginine:glycine amidinotransferase and arginases
di: E. S. Alekseevskaya, et al.
Pubblicazione: (2018-03-01)

Malate and Aspartate Increase L-Arginine and Nitric Oxide and Attenuate Hypertension
di: Entai Hou, et al.
Pubblicazione: (2017-05-01)

Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.
di: Curry, S, et al.
Pubblicazione: (1995)

Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization
di: Chang CY, et al.
Pubblicazione: (2016-12-01)

Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor αIIbβ3 and activated platelets
di: Marcinkiewicz C, et al.
Pubblicazione: (2017-05-01)

Seroprevalence of foot and mouth disease in Tanzania
di: D.P. Mdetele, et al.
Pubblicazione: (2014-04-01)